- A company is conducting clinical trials and seeking drug approval for the U.S. market under the FDA.
IAC operates Angi and Care.com as digital businesses, while Intuitive Surgical received FDA clearance for its systems.
5 reports, 2 independent
Updated Aug 3
Gone quiet
- Reports
- 5
- Developments
- 1
- Repetition
- 80%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
IAC operates Angi and Care.com as digital businesses, while Intuitive Surgical received FDA clearance for its systems.
Who's involved
What this event is mainly aboutKeep exploring
Part of
A company is conducting clinical trials and seeking drug approval for the U.S. market under the FDA.Also in this story
- A partnership with BARDA has accelerated the development of SCY-247 for the company.
- A company plans to submit regulatory applications to the FDA, EMA, and Australian TGA.
- Approval leads to procurement process initiation.
- UroGen Pharma Ltd., headquartered in Princeton, is seeking FDA approval for its products for the U.S. market.
The entities involved
-
IAC
American media and Internet company
-
Intuitive Surgical
American corporation
- FDA
Coverage
Newest first; wire copies grouped- financialcontent.com
- StockStory1 Volatile Stock with Promising Prospects and 2 We Turn Down A highly volatile stock can deliver big gains - or just as easily wipe out a portfolio if things go south. While some investors embrace ri
- StockStory1 Small-Cap Stock with Exciting Potential and 2 We Brush Off Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opport
- StockStoryIAC (NASDAQ:IAC) Misses Q2 Revenue Estimates Digital media conglomerate IAC (NASDAQGS:IAC) missed Wall Street’s revenue expectations in Q2 CY2025, with sales falling 7.5% year on year to $586.9 milli
- Unknown outlet